Corporate document

References

References

  • Amann J, Blasimme A, Vayena E et al. (2020) Precise4Q consortium. Explainability for artificial intelligence in healthcare: a multidisciplinary perspective. BMC Medical Informatics and Decision Making 20(1): 310

  • Amaran S, Sahinidis NV, Sharda B, Bury SJ (2015) Simulation optimization: a review of algorithms and applications. Annals of operational research 240: 351–80

  • Boehm KM, Aherne EA, Ellenson L et al. (2022) Multimodal data integration using machine learning improved risk stratification of high-grade serous ovarian cancer. Nature 3: 723–33

  • Branch HJ, Rodriguez Cefalu J, McHugh J, Hujer L, Bahl A et al. (2022) Evaluating the susceptibility of pre-trained language models via handcrafted adversarial examples [online; accessed 15 July 2024]

  • Cabinet Office (2018) Data Ethics Framework [online; accessed 3 June 2024]

  • Central Digital and Data Office and Department for Science, Innovation and Technology (DSIT; 2021) Algorithmic Transparency Recording Standard [online; accessed 1 July 2024]

  • Chhatwal J, Yildrim IF, Balta D et al. (2024). Can large language models generate conceptual health economic models? [online; accessed 25 June 2024]

  • Cochrane (2024) Artificial intelligence (AI) technologies in Cochrane. Webinar (9 May 2024) [online; accessed 29 May 2024]

  • Collins GS, Moons KGM, Dhiman P et al. (2024) TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ 385: e078378

  • Coombs L, Orlando A, Wang X et al. (2022) A machine learning framework supporting prospective clinical decisions applied to risk prediction in oncology. NPJ Digital Medicine 5(1): 117

  • Cowley HP, Robinette MS, Matelsky JK et al. (2023) Using machine learning on clinical data to identify unexpected patterns in groups of COVID-19 patients. Nature Scientific Reports 13(1): 2236

  • Datta S, Lee K, Paek H et al. (2024) AutoCriteria: a generalizable clinical trial eligibility criteria extraction system powered by large language models. Journal of the American Medical Informatics Association 31(2): 375–85

  • Department for Health & Social Care (DHSC; 2021) A guide to good practice for digital and data-driven health technologies [online; accessed 3 June 2024]

  • Department for Science, Innovation and Technology (DSIT; 2023) A pro-innovation approach to AI regulation [online; accessed 26 June 2024]

  • Department for Science, Innovation and Technology (DSIT; 2019) The Centre for Data Ethics and Innovation's approach to the governance of data-driven technology [online; accessed 3 June 2024]

  • Department for Science, Innovation and Technology (DSIT), Office for Artificial Intelligence and Centre for Data Ethics and Innovation (2019) A guide to using artificial intelligence in the public sector [online; accessed 3 June 2024]

  • European Medicines Agency (2023) Draft reflection paper on the use of Artificial Intelligence (AI) in the medicinal product lifecycle [online; accessed 3 June 2024]

  • European Parliament (2024) Briefing: Artificial intelligence act [online; accessed 13 June 2024]

  • Elliott A (2022) Better, broader, safer: using health data for research and analysis (the Goldacre review). Journal of Radiological Protection 42(3)

  • Fleurence RL, Bian J, Wang X et al. (2024) Generative AI for health technology assessment: opportunities, challenges, and policy considerations [online; accessed 17 July 2024]

  • Gajjar D (2024) The Parliamentary Office of Science and Technology artificial intelligence (AI) glossary [online; accessed 26 June 2024]

  • Gervasi SS, Chen IY, Smith-McLallen A et al. (2022) The potential for bias in machine learning and opportunities for health insurers to address it. Health Affairs 41(2): 212–18

  • Guidelines International Network (GIN, 2024) Working groups: artificial intelligence. [online, accessed 30 May 2024]

  • Harrer S, Shah P, Antony B, Hu J (2019) Artificial Intelligence for Clinical Trial Design. Trends in Pharmacological Sciences 40(8): 577–91

  • ISPOR (2024) Revolutionizing systematic reviews: harnessing the power of AI. Webinar (21 May 2024) [online: accessed 29 May 2024]

  • Keloth VP, Banda JM, Gurley M et al. (2023) Representing and utilizing clinical textual data for real world studies: an OHDSI approach. Journal of Biomedical Informatics 142: 104343

  • Leslie D (2019) Understanding artificial intelligence ethics and safety: A guide for the responsible design and implementation of AI systems in the public sector. The Alan Turing Institute [online: accessed 19 July 2024]

  • Li I, Pan J, Goldwasser J et al. (2022) Neural natural language processing for unstructured data in electronic health records: a review. Computer Science Review 46

  • Ling AY, Montez-Rath ME, Carita P et al (2023) An overview of current methods for real-world applications to generalize or transport clinical trial findings to target populations of interest. Epidemiology 34(5): 627–36

  • MHRA (2024) Policy paper: Impact of AI on the regulation of medical products. [online; accessed 13 June 2024]

  • National Cyber Security Centre (2024) AI and cyber security: what you need to know [online; accessed 15 July 2024]

  • OHDSI (Observational Health Data Sciences and Informatics) Standardised data: The OMOP Common Data Model [online; accessed 4 June 2024]

  • Padula WV, Kreif N, Vanness DJ et al. (2022) Machine learning methods in health economics and outcomes research—the PALISADE checklist: a good practices report of an ISPOR task force. Value In Health 25(7): 1063–80

  • Piciocchi A, Cipriani M, Messina M et al. (2024) Unlocking the potential of synthetic patients for accelerating clinical trials: results of the first GIMEMA experience on acute myeloid leukemia patients. EJHaem 5(2): 353–9

  • Pfitzner B, Steckhan N, Arnrich B (2021) Federated learning in a medical context: a systematic literature review. ACM Transactions on Internet Technology 21(2): 1–31

  • Reason T, Rawlinson W, Langham J et al. (2024a) Artificial intelligence to automate health economic modelling: a case study to evaluate the potential application of large language models. Pharmacoeconomics Open 8(2): 191–203

  • Reason T, Benbow E, Langham J et al. (2024b) Artificial intelligence to automate network meta-analyses: four case studies to evaluate the potential application of large language models. Pharmacoeconomics Open 8(2): 205–20

  • Saleh M, Wazery Y, Ali A (2024) A systematic literature review of deep learning-based text summarization: Techniques, input representation, training strategies, mechanisms, datasets, evaluation, and challenges. Expert Systems with Applications 252(A): 124153

  • Shivade C, Raghavan P, Fosler-Lussier E et al. (2014) A review of approaches to identifying patient phenotype cohorts using electronic health records. Journal of the American Medical Informatics Association 21(2): 221–30

  • Soroush A, Glicksberg BS, Zimlichman E et al. (2024) Large language models are poor medical coders – benchmarking of medical code querying. NEJM AI 1(5)

  • Velupillai S, Suominen H, Liakata M et al. (2018) Using clinical Natural Language Processing for health outcomes research: Overview and actionable suggestions for future advances. Journal of Biomedical Informatics 88: 11–9

  • Zemplényi A, Tachkov K, Balkanyi L et al. (2023) Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment. Frontiers in Public Health 11: 1088121

ISBN: 978-1-4731-6650-9